Celcuity Inc. (CELC) vs Pulse Biosciences, Inc. (PLSE)

A side-by-side comparison of Celcuity Inc. and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELC vs PLSE

growth of $100 · dividends reinvested · last 9y
CELC +415.2% (+20.0%/yr)PLSE +247.8% (+14.9%/yr)CELC compounded faster over this window
02004006008001kStart $1002019202120232025$515$348
CELC PLSE

CELC vs PLSE: by the numbers

  • •CELC is the larger company ($3.50B vs $3.44B market cap).
  • •Both run net losses; CELC's is the smaller (0.00% vs -6755.78% net margin).

Metrics side by side

Valuation

MetricCELCPLSE
P/S ratioN/A2902.43
P/B ratioN/A34.57

Profitability

MetricCELCPLSE
Gross margin0.00%-360.00%
Operating margin0.00%-21982.57%
Net margin0.00%-6755.78%
ROEN/A-80.46%
ROIC-28.15%-79.40%

Growth (annualized)

MetricCELCPLSE
Total return CAGR (5Y)34.40%19.76%

Frequently asked

How have CELC and PLSE total returns compared?
Over the past 5 years, CELC delivered 34.40% and PLSE delivered 19.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.